BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 311545)

  • 1. [Control of the immunological reactivity in cervical cancer in the process of radiation therapy].
    Shiriĭ AV
    Vopr Onkol; 1979; 25(1):63-8. PubMed ID: 311545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blast transformation of the peripheral lymphocytes in cervical cancer during the radiotherapy process].
    Shiriĭ AV
    Vopr Onkol; 1975; 21(3):35-40. PubMed ID: 1130018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological status of cervical cancer patients].
    Il'in IV; Dekster LI; Letskiĭ VB
    Med Radiol (Mosk); 1979 Aug; 24(8):18-22. PubMed ID: 314558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status in untreated cervical cancer patients.
    Satam MN; Nadkarni JJ; Nadkarni JS; Rajpal RM
    Neoplasma; 1981; 28(1):111-6. PubMed ID: 6974311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of lysozyme chloride on immune responses of patients with uterine cervical cancer].
    Yamaoka K; Yoshioka T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1803-9. PubMed ID: 6882004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive and cytogenetic effects of pelvic irradiation on the peripheral lymphocytes of patients with cervical cancer. One year follow-up.
    Vucković-Dekić L; Spremo B; Stanojević-Bakić N; Garzicić B; Durbaba M
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):63-6. PubMed ID: 7503637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of radiotherapy on T lymphocyte subpopulations analyzed by monoclonal antibodies].
    Shikaura S; Sogawa M; Akagi K; Hasegawa T; Sawada S; Tanaka Y; Sawaragi I
    Gan No Rinsho; 1988 Mar; 34(3):305-9. PubMed ID: 3258643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and immunological parallels in soft tissue tumors].
    Gladikov IuV; Klimenkov AA; Kadagidze ZG; Kupin VI; Sveshinina IuA
    Vopr Onkol; 1978; 24(12):3-8. PubMed ID: 735006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological reactivity of the body in cancer of the corpus uteri].
    Gorodilova VV; Iatskovskaia NL
    Vopr Onkol; 1978; 24(3):10-3. PubMed ID: 644958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of rosette forming T-lymphocytes in carcinoma of cervix uteri.
    Utreja SR; Ramdeo IN; Kalra VB; Lodha SK; Sareen PM
    Indian J Cancer; 1980 Dec; 17(4):216-9. PubMed ID: 6971798
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte subpopulations from patients with cervical uterine carcinoma undergoing radiation therapy.
    Aguilar-Santelises M; Santos-Argumedo L; Rodríguez-Coquiez G; Jiménez-Zamudio L; García-García G
    Rev Latinoam Microbiol; 1983; 25(3):203-11. PubMed ID: 6672938
    [No Abstract]   [Full Text] [Related]  

  • 15. T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
    Ilyin NV; Dexter LI; Bochman YaV
    Neoplasma; 1979; 26(4):423-7. PubMed ID: 392325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the correlation between immune responses and histopathological changes of primary lesion in patients with cervical cancer following radiation therapy (author's transl)].
    Shiozawa I
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1986-94. PubMed ID: 7211216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
    Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
    Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation (author's transl)].
    Palencia C; Wicke L; Kärcher KH; Gitsch E; Hernuss P; Steffen C
    Wien Klin Wochenschr; 1976 Aug; 88(15):495-501. PubMed ID: 997530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of small doses of ionizing radiation on selected antioxidant and immunologic parameters in patients with cervical cancer].
    Frantsiiants EM; Rozenko LIa; Zlatnik EIu; Zakora GI
    Vopr Onkol; 2002; 48(6):731-4. PubMed ID: 12530277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modulating action of interferon preparations on cellular reactions of antitumor immunity].
    Mkrtchian LN; Ter-Pogosian ZR; Sarkisian OM; Gevorkian RA; Movsesian EA
    Vopr Onkol; 1983; 29(8):7-11. PubMed ID: 6351429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.